PlainRecalls
FDA Devices Critical Class I Ongoing

CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter Defibrillators

Reported: June 28, 2023 Initiated: May 10, 2023 #Z-1752-2023

Product Description

CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter Defibrillators

Reason for Recall

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

Details

Units Affected
7994 units
Distribution
US Nationwide - Worldwide Distribution
Location
Mounds View, MN

Frequently Asked Questions

What product was recalled?
CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter Defibrillators. Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). Units affected: 7994 units.
Why was this product recalled?
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 28, 2023. Severity: Critical. Recall number: Z-1752-2023.